Does OBINUTUZUMAB Cause Lymphadenopathy? 192 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 192 reports of Lymphadenopathy have been filed in association with OBINUTUZUMAB (Gazyva). This represents 1.4% of all adverse event reports for OBINUTUZUMAB.
192
Reports of Lymphadenopathy with OBINUTUZUMAB
1.4%
of all OBINUTUZUMAB reports
11
Deaths
33
Hospitalizations
How Dangerous Is Lymphadenopathy From OBINUTUZUMAB?
Of the 192 reports, 11 (5.7%) resulted in death, 33 (17.2%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Lymphadenopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 192 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DUPILUMAB (760)
DOXORUBICIN (705)
VINCRISTINE (649)
Which OBINUTUZUMAB Alternatives Have Lower Lymphadenopathy Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE